Chorus Aviation Inc.
TSX:CHR.TOAirlines, Airports & Air Services
+$0.15 today
- Market cap
- $815.92M
- Beta
- 1.57
- P/E (TTM)
- 8.7
- EPS (TTM)
- $2.86
- Dividend yield
- 1.21%
Volume 0.05M
Average 0.03M
CHR.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Chorus Aviation Inc.TSX: CHR.TO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month research & development was CA$0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CHR.TO compares with its peers on the latest reported figures
- CHR.TO's LTM Mar 2026 research & development of CA$0 is the 3rd highest of the 9 companies compared; the peer median is CA$0.
- Research & development amounts to 0.0% of revenue for CHR.TO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$12.33M | +0.9% | +30.0% | 1.5% | |
| LTM Mar 2026 | CA$1.29M | +325.0% | -23.9% | 0.6% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 | — | — | 0.0% | |
| Peer median (excluding CHR.TO) | CA$0 | +162.9% | +3.0% | 0.0% | |
Competitors are the stored peer set for CHR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.02B | 1.6B | 1.4B | 1.4B | 1.32B |
| Cost of Revenue | 817.64M | 1.17B | 1.24B | 1.13B | 1.05B |
| Gross Profit | 205.63M | 423.4M | 337.13M | 270.89M | 264.86M |
| Gross Margin | 20.1% | 26.5% | 24.1% | 19.3% | 20.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 209.84M | 0 | 0 |
| Operating Expenses | 134.65M | 235.13M | 270.08M | 178.25M | 165.26M |
| Depreciation & Amortization | 201.13M | 182.11M | 91.48M | 116.39M | 107.28M |
| EBITDA | 270.46M | 360.85M | 271.36M | 165.54M | 223.53M |
| EBITDA Margin | 26.4% | 22.6% | 19.4% | 11.8% | 17.0% |
| Operating Income | 70.98M | 188.27M | 158.53M | 92.65M | 99.61M |
| Operating Margin | 6.9% | 11.8% | 11.3% | 6.6% | 7.6% |
| Interest Income | 880K | 4.05M | 2.18M | 4.37M | 3.82M |
| Interest Expense | 97.21M | 104.89M | 42.84M | 51.76M | 17.62M |
| Other Income / Expenses | (98.86M) | (114.42M) | (102.43M) | (95.26M) | (965K) |
| Income Before Tax | (27.88M) | 73.85M | 137.04M | (2.61M) | 98.64M |
| Pre-Tax Margin | -2.7% | 4.6% | 9.8% | -0.2% | 7.5% |
| Income Tax Expense | (7.4M) | 21.93M | 35.41M | 13.15M | 19.9M |
| Net Income | (20.49M) | 48.89M | 101.35M | (158.5M) | 78.74M |
| Net Margin | -2.0% | 3.1% | 7.2% | -11.3% | 6.0% |
| EPS (Basic) | (0.83) | 0.94 | 2.36 | (10.10) | 3.05 |
| EPS (Diluted) | (0.83) | 0.91 | 2.29 | (10.10) | 3.01 |
| Weighted Avg Shares | 24.79M | 27.78M | 27.91M | 27.4M | 25.79M |
| Weighted Avg Shares (Diluted) | 24.79M | 28.44M | 28.75M | 27.4M | 26.19M |
Chorus Aviation Inc.
TSX:CHR.TO
Intrinsic Alpha fair value
Locked
Current Price
$36.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.